Adial Pharmaceuticals (ADIL) Capital Leases (2022 - 2023)
Adial Pharmaceuticals' Capital Leases history spans 2 years, with the latest figure at $506000.0 for Q1 2023.
- For Q1 2023, Capital Leases fell 41.71% year-over-year to $506000.0; the TTM value through Mar 2023 reached $506000.0, down 41.71%, while the annual FY2022 figure was $492000.0, N/A changed from the prior year.
- Capital Leases for Q1 2023 was $506000.0 at Adial Pharmaceuticals, up from $492000.0 in the prior quarter.
- Across five years, Capital Leases topped out at $892000.0 in Q2 2022 and bottomed at $492000.0 in Q4 2022.